“…A worldwide distribution of these enzymes has been reported (4), and in some settings (e.g., Argentina, Greece, Japan, Spain, and Taiwan), the CTX-M-type enzymes are more prevalent than TEM-and SHV-type ESBLs (35,36,43,45,46). In Europe, where the TEM-and SHV-type ESBLs were first reported (20,40) and are widespread overall (12,26,30,33,37), a rapid and massive dissemination of isolates producing CTX-M-type ESBLs has recently been reported in some countries (1,16,17,21,25,44) and is a matter of major concern.…”